Heart surgery bleeding breakthrough? new study tests Desmopressin's Clot-Boosting power
NCT ID NCT07179991
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how desmopressin, a drug that helps blood clot, affects platelet function in 100 adults undergoing heart surgery with a heart-lung machine. Researchers will use a special blood test called TEG6s to measure clotting at several time points before and after giving desmopressin. The goal is to better understand how the drug works and whether it can reduce the need for blood transfusions after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Desmopressin (DDAVP)
- What this could lead to
- If successful, this could help doctors better understand how desmopressin improves clotting, potentially reducing blood transfusions in heart surgery patients.
- What could go wrong
- This is a small, early-stage observational study focused on measuring effects, not proving clinical outcomes. Results may not change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAOPERATIVE BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple infusion make sinus surgery safer and clearer?
- New Blood-Saving technique could transform liver surgery
- Which drug keeps sinus surgery cleaner? dexmedetomidine vs. nitroglycerin
- New surgical patch aims to stop bleeding faster in liver operations
- New patch aims to stop bleeding faster in keyhole surgery
- New gel stops bleeding during spine surgery